A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data

Yazar
Lassila, R.
Zulfikar, B.
Bulent, A.
Kavakli, K.
Gringeri, A.
Leissinger, C.
Negrier, C.
Berntorp, E.
Windyga, J.
Serban, M.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/13886
Koleksiyonlar